Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 333

1.

Architecture of the human interactome defines protein communities and disease networks.

Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW.

Nature. 2017 May 25;545(7655):505-509. doi: 10.1038/nature22366. Epub 2017 May 17.

2.

SerpinC1/Antithrombin III in kidney-related diseases.

Lu Z, Wang F, Liang M.

Clin Sci (Lond). 2017 May 1;131(9):823-831. doi: 10.1042/CS20160669. Review.

3.

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications.

Kraft J, Sunder-Plassmann R, Mannhalter C, Quehenberger P, Tews G, Langer M, Pabinger I.

Ann Hematol. 2017 Jun;96(6):1023-1031. doi: 10.1007/s00277-017-2965-2. Epub 2017 Mar 30.

PMID:
28361296
4.

SERPINC1 gene mutations in antithrombin deficiency.

Mulder R, Croles FN, Mulder AB, Huntington JA, Meijer K, Lukens MV.

Br J Haematol. 2017 Jul;178(2):279-285. doi: 10.1111/bjh.14658. Epub 2017 Mar 20.

PMID:
28317092
5.

Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.

Alhenc-Gelas M, Plu-Bureau G, Hugon-Rodin J, Picard V, Horellou MH; GFHT study group on Genetic Thrombophilia.

Thromb Haemost. 2017 Jun 2;117(6):1040-1051. doi: 10.1160/TH16-08-0635. Epub 2017 Mar 16.

PMID:
28300866
6.

High levels of latent antithrombin in plasma from patients with antithrombin deficiency.

de la Morena-Barrio M, Sandoval E, Llamas P, Wypasek E, Toderici M, Navarro-Fernández J, Rodríguez-Alen A, Revilla N, López-Gálvez R, Miñano A, Padilla J, de la Morena-Barrio B, Cuesta J, Corral J, Vicente V.

Thromb Haemost. 2017 May 3;117(5):880-888. doi: 10.1160/TH16-11-0866. Epub 2017 Feb 23.

PMID:
28229161
7.

Whole Exome Sequencing Reveals Severe Thrombophilia in Acute Unprovoked Idiopathic Fatal Pulmonary Embolism.

Halvorsen M, Lin Y, Sampson BA, Wang D, Zhou B, Eng LS, Um SY, Devinsky O, Goldstein DB, Tang Y.

EBioMedicine. 2017 Mar;17:95-100. doi: 10.1016/j.ebiom.2017.01.037. Epub 2017 Jan 31.

8.

Subtypes of SERPINC1 mutations and the thrombotic phenotype of inherited antithrombin deficient individuals in Chinese Han population.

Wang D, Cui G, Hu S, Wang DW.

Blood Cells Mol Dis. 2016 Nov;62:38-41. doi: 10.1016/j.bcmd.2016.10.029. Epub 2016 Nov 12.

PMID:
27863268
9.

A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.

Su J, Shu L, Zhang Z, Cai L, Zhang X, Zhai Y, Liu J.

Oncotarget. 2016 Nov 22;7(47):76882-76890. doi: 10.18632/oncotarget.12349.

10.

Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.

Peltier J, Roperch JP, Audebert S, Borg JP, Camoin L.

J Proteomics. 2016 Oct 4;148:139-48. doi: 10.1016/j.jprot.2016.07.031. Epub 2016 Aug 2.

PMID:
27492143
11.

Cellular folding pathway of a metastable serpin.

Chandrasekhar K, Ke H, Wang N, Goodwin T, Gierasch LM, Gershenson A, Hebert DN.

Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6484-9. doi: 10.1073/pnas.1603386113. Epub 2016 May 24.

12.

Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.

de la Morena-Barrio ME, Martínez-Martínez I, de Cos C, Wypasek E, Roldán V, Undas A, van Scherpenzeel M, Lefeber DJ, Toderici M, Sevivas T, España F, Jaeken J, Corral J, Vicente V.

J Thromb Haemost. 2016 Aug;14(8):1549-60. doi: 10.1111/jth.13372. Epub 2016 Jun 29.

PMID:
27214821
13.

A common missense variant in exon 5 of antithrombin gene (SERPINC1) in Indian patients with thrombosis.

Deshpande R, Kulkarni B, Ghosh K, Shetty S.

Thromb Res. 2016 Jul;143:1-2. doi: 10.1016/j.thromres.2016.04.012. Epub 2016 Apr 23. No abstract available.

PMID:
27161325
14.

Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.

Navarro-Fernández J, de la Morena-Barrio ME, Padilla J, Miñano A, Bohdan N, Águila S, Martínez-Martínez I, Sevivas TS, de Cos C, Fernández-Mosteirín N, Llamas P, Asenjo S, Medina P, Souto JC, Overvad K, Kristensen SR, Corral J, Vicente V.

Thromb Haemost. 2016 Jul 4;116(1):146-54. doi: 10.1160/TH15-11-0871. Epub 2016 Apr 21.

PMID:
27098529
15.

Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.

Toderici M, de la Morena-Barrio ME, Padilla J, Miñano A, Antón AI, Iniesta JA, Herranz MT, Fernández N, Vicente V, Corral J.

PLoS One. 2016 Mar 22;11(3):e0152159. doi: 10.1371/journal.pone.0152159. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0159987.

16.

Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency.

Kovac M, Mitic G, Mikovic Z, Mandic V, Djordjevic V, Muszbek L, Bereczky Z.

Thromb Res. 2016 Mar;139:111-3. doi: 10.1016/j.thromres.2016.01.018. Epub 2016 Jan 27. No abstract available.

PMID:
26916305
17.

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

Gindele R, Oláh Z, Ilonczai P, Speker M, Udvari Á, Selmeczi A, Pfliegler G, Marján E, Kovács B, Boda Z, Muszbek L, Bereczky Z.

J Thromb Haemost. 2016 Apr;14(4):704-15. doi: 10.1111/jth.13252. Epub 2016 Feb 16.

18.

Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.

Yamada T, Kanda Y, Takayama M, Hashimoto A, Sugihara T, Satoh-Kubota A, Suzuki-Takanami E, Yano K, Iida S, Satoh M.

Glycobiology. 2016 May;26(5):482-92. doi: 10.1093/glycob/cww001. Epub 2016 Jan 7.

19.

Identification and function probing of an antithrombin IIIβ conformation-specific antibody.

Jin Y, Yegneswaran S, Gu JM, Gritzan U, Schönfeld DL, Paz P, Patel C, Dittmer F, Strerath M, Bringmann P, Kauser K, Myles T, Murphy JE, Hermiston TW.

J Thromb Haemost. 2016 Feb;14(2):356-65. doi: 10.1111/jth.13198. Epub 2016 Jan 6.

20.

Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.

Campello E, Spiezia L, Radu CM, Bulato C, Gavasso S, Tormene D, Woodhams B, Dalla Valle F, Simioni P.

Thromb Haemost. 2016 Jan;115(1):81-8. doi: 10.1160/TH15-04-0286. Epub 2015 Sep 10.

PMID:
26354831

Supplemental Content

Support Center